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Abstract: Epidemiological studies suggest that chronic alcohol consumption is a lifestyle risk factor
strongly associated with colorectal cancer development and progression. The aim of the present
study was to examine the effect of ethanol (EtOH) on survival and progression of three different
colon cancer cell lines (HCT116, HT29, and Caco-2). Our data showed that EtOH induces oxidative
and endoplasmic reticulum (ER) stress, as demonstrated by reactive oxygen species (ROS) and ER
stress markers Grp78, ATF6, PERK and, CHOP increase. Moreover, EtOH triggers an autophagic
response which is accompanied by the upregulation of beclin, LC3-II, ATG7, and p62 proteins.
The addition of the antioxidant N-acetylcysteine significantly prevents autophagy, suggesting
that autophagy is triggered by oxidative stress as a prosurvival response. EtOH treatment also
upregulates the antioxidant enzymes SOD, catalase, and heme oxygenase (HO-1) and promotes
the nuclear translocation of both Nrf2 and HO-1. Interestingly, EtOH also upregulates the levels of
matrix metalloproteases (MMP2 and MMP9) and VEGF. Nrf2 silencing or preventing HO-1 nuclear
translocation by the protease inhibitor E64d abrogates the EtOH-induced increase in the antioxidant
enzyme levels as well as the migration markers. Taken together, our results suggest that EtOH
mediates both the activation of Nrf2 and HO-1 to sustain colon cancer cell survival, thus leading to
the acquisition of a more aggressive phenotype.
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1. Introduction
Colorectal cancer (CRC) is one of the most widespread cancers in the world [1]. Epidemiological data
show the highest incidence of this tumor in countries characterized by high indices of development, such as
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Australia, Europe, and North America [2]. This geographic variability has been linked to differences in
environment and lifestyle [2]. Numerous risk factors have been correlated with the development of CRC,
including genetic factors, inflammation, intestinal microflora composition, as well as harmful lifestyle
habits, such as smoking, high consumption of red meats, and alcohol intake [3].
Chronic and heavy alcohol consumption, a common lifestyle habit of developed countries,
has been associated with an increased risk of developing gastrointestinal cancers, including CRC [4,5].
The association between alcohol drinking and CRC is dose-dependent. A recent meta-analysis of
literature from 1996 to 2013 shows that compared with non-occasional drinkers, the relative risk
was 0.97 for subjects who drink low doses of ethanol (≤12.5 g/day), 1.04 for moderate drinkers
(12.6–49.9 g/day), and 1.21 for heavy drinkers (≥50 g/day) [6]. Alcohol’s influence can also vary based
on individual differences in enzymes involved in alcohol metabolism. For example, the presence of
ADH1B [7] or ADH1C*1—two polymorphisms of alcohol dehydrogenase (ADH)—has been associated
with an increased risk of CRC [8]. In addition to act as a risk factor for carcinogenesis, many studies
indicate that chronic alcohol consumption also promotes colon tumor progression [6–9].
The mechanisms proposed to explain the role of alcohol in CRC promotion include acetaldehyde
mutagenic effects, oxidative stress increase, and folic acid deficiency [10,11]. Acetaldehyde, which is
produced by ADH, cytochrome P450 2E1 (CYP2E1), or catalase, is considered the most potent carcinogenic
metabolite of ethanol [12]. It is highly reactive and mutagenic by forming protein and DNA adducts,
which result in DNA mutations and reactive oxygen species (ROS) production [10]. In addition to
acetaldehyde, ROS have been also shown to contribute to colon carcinogenesis [13]. In alcoholics, ROS are
predominantly generated through CYP2E1, which is induced by chronic alcohol consumption in the mucosa
of the esophagus and colon [14]. CYP2E1-induced ROS production has been correlated with the generation
of lipid peroxidation products, such as 4-hydroxynonenal and malondialdehyde. These compounds can
bind to DNA forming etheno-DNA adducts which are highly carcinogenic [14,15].
It is well known that chronic inflammation also promotes colorectal cancer carcinogenesis.
To this regard, it has been reported that the persistent exposure of enterocytes to an inflammatory
environment induces molecular alterations favoring tumor development [16]. However, following
chronic inflammation epithelial cells can activate adaptive mechanisms to reduce the deleterious
action of oxidative stress and survival [17]. The major mechanism by which cancer cells increase their
antioxidant proteins is through the activation of nuclear factor erythroid 2-related factor 2 (Nrf2),
a transcription factor involved in the transcription of antioxidant and detoxifying factors in response
to oxidative stress [18,19]. Nrf2 is normally sequestered in the cytoplasm in an inactive complex
with kelch-like ECH-associated protein 1 (Keap1). ROS induce oxidation of critical cysteines of
Keap1 and its dissociation from Nrf2 [20]. This event allows Nrf2 to migrate into the nucleus and form
transcriptionally active complexes with other proteins, such as Mafs (musculoaponeurotic fibrosarcoma
proteins). Such molecular cascades lead to the increase in the transcription of cytoprotective and
antioxidant genes, such as superoxide dismutase (SOD), catalase, and heme oxygenase (HO-1),
thus favoring cancer cell survival [21]. In addition, previous reports showed that Nrf2, beyond
its antioxidant role, also exhibits a protumorigenic activity promoting proliferation and sustaining
migration and invasiveness of cancer cells [22]. To this regard, overexpression of Nrf2 has been
reported in colon cancer cells and has been related with tumor progression and poor prognosis [23].
Similarly, HO-1, the main target of Nrf2, can also exert a double role in cancer [24,25]. In fact,
HO-1 may counteract ROS-mediated carcinogenesis by favoring heme breakdown into biliverdin;
however, its overexpression has been shown to provide tumor cells with a more aggressive
survival phenotype [26]. Finally, under oxidative stress conditions HO-1 translocates into the
nucleus, where it interacts with Nrf2 preventing its GSK3β-mediated phosphorylation coupled with
ubiquitin–proteasomal degradation, thereby prolonging Nrf2 nuclear accumulation [27].
The aim of the present research was to evaluate the role of Nrf2/HO-1 axis in promoting colon
cancer survival and progression under ethanol stimulation. Our data suggest that ethanol induces both
Nrf2 and HO-1 nuclear translocation in response to oxidative and endoplasmic reticulum (ER) stress
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activation and that this event confers resistance to oxidative stress and contributes to the acquisition of
a more invasive phenotype.
2. Results
2.1. Effects of Ethanol in Colon Cancer Cell Viability
To evaluate the effect of ethanol (EtOH) on colon cancer cells, different colon cancer cell
lines (HCT116, HT29, and Caco-2 cells) were exposed to a range of EtOH concentrations (30–300
mM) for different durations. Then, the viability was assessed by 3-(4,5-dimethyl- thiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT) assay which evaluates the mitochondrial dehydrogenase activity,
as reported in methods. As shown in Figure 1A, compared with untreated cells, EtOH, also at high
doses, displayed a scarce effect on cell viability at 72 h of treatment, but slightly reduced cell viability
at 24 and 48 h, in particular in HT29 and Caco-2 cells. Our data also demonstrated that staining the
cells with propidium iodide (PI), a membrane impermeant dye that is generally excluded from viable
cells, evidenced that EtOH treatment did not induce cell death in this condition, in which we observed
a reduction of cell viability. Thus, the reduced viability assessed by MTT assay in EtOH-treated cells
for 24 or 48 h could be due to cell proliferation arrest or reduced metabolic activity of cells.
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Figure 1. Ethanol effect on colon cancer cell viability and colony generation ability. (A) HCT116, HT29,
and Caco-2 cells (7× 103) were incubated in the presence of various doses of EtOH (30–300 mM) for the
indicated times. Cell viability was assessed by 3-(4,5-dimethyl- thiazol-2-yl)-2,5-diphenyltetrazolium
bromide (MTT) assay and expressed as the percentage of the viable control cells in untreated cultures.
Values are the means of three independent experiments ± S.E. (*) p < 0.05 compared to the control.
(B) The clonogenic assay was performed seeding a single cell suspension (200 cells/well) in 6-well plate
and after 48 h treating it with different doses of EtOH. Clonogenic ability was evaluated after 14 days.
Photographic images of cells after staining with crystal violet were reported. Results are representative
of three independent experiments.
Morphological observations of cells confirmed the absence of cytotoxicity in all the conditions
tested also prolonging EtOH treatment (1 week), leading to the conclusion that colon cancer cells
survive even under treatment with high doses of ethanol.
To explore the ability of EtOH to counteract the production of colonies, HCT116 cells were plated
with or without the addition of different doses of EtOH, and maintained in culture for additional 14 days
to allow the formation of colonies. The results demonstrated no significant difference between control and
EtOH-treated cells (Figure 1B), thus suggesting that the compound does not affect colony formation.
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To evaluate the biochemical mechanisms linking high doses of alcohol consumption and
colon cancer progression, the next experiments were performed using100 mM and 300 mM EtOH,
two different high concentrations of alcohol.
2.2. Ethanol Treatment Induces Oxidative Stress in Colon Cancer Cells
EtOH metabolism produces acetaldehyde and reactive oxygen species (ROS), which have been
correlated with the toxic effects of the compound [28]. To ascertain ROS generation in our model
system, we performed fluorescence microscopy analysis by employing the fluorochrome H2DCFDA—a
general indicator of intracellular ROS levels. As shown in Figure 2A, EtOH treatment rapidly increases
the number of green fluorescent cells, which are indicative of intracellular ROS production. The effect
appears at 10 min of exposure to EtOH, then rapidly decreases with the time of treatment.
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Figure 2. Ethanol induces oxidative and ER stress in colon cancer cells. (A) HCT116 cells (7 × 103)
were treated with 300 mM EtOH for the indicated times. Reactive oxygen species (ROS) production
was assayed by H2DCFDA staining. Images were taken by a Leica DC300F microscope (200× original
magnification) using a FITC filter. Results are representative of three independent experiments. (B,C)
Cells (1 × 105) were treated with 100 or 300 mMEtOH for the indicated times. Cell lysates (30 µg) were
analyzed by Western blotting for COX2, iNOS, Hsp90, and Hsp60 (B) or Grp78, CHOP, ATF6 and its
fragmented form (ATF6f) and PERK (C). Densitometric analysis of bands was carried out as reported
in Material and Methods and data were normalized to β-actin expression. Results are from three
independent experiments and statistical significance was determined using one-way ANOVA followed
by Bonferroni’s test. (*) p < 0.05 and (**) p < 0.01 compared to the untreated sample.
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Cyclooxygenase 2 (COX2) and inducible nitric oxide synthase (iNOS) are two important enzymes
expressed in response to a variety of stimuli that mediate inflammatory processes and tumor
progression [29]. Western blotting analysis shows that COX2 and iNOS proteins are significantly
up-regulated in EtOH-treated HCT116 cells. In particular, treatment for 3 h with 300 mM EtOH
increases the levels of the enzymes respect to untreated control by 2.7 and 2.2 fold, respectively
(Figure 2B, p < 0.05).
Moreover, we evaluated the effect of EtOH on the levels of Hsp90 and Hsp60, two heat shock
proteins induced by cellular stress [30,31]. As shown in Figure 2B, the exposure to 100 and 300 mM
EtOH for 3 h induces a significant increase of both Hsp90 and Hsp60 compared to the untreated
condition (p < 0.05).
2.3. Ethanol Treatment Induces ER Stress in Colon Cancer Cells
Oxidative stress can be responsible for accumulation of unfolded-proteins and induction of ER
stress [32]. To explore the ability of EtOH to activate ER stress in colon cancer cells, we analyzed
the levels of glucose-regulated protein of 78 kDa (GRP78), which is a chaperone interacting with
misfolded proteins and an indicator of ER stress, and CCAAT/enhancer-binding protein homologous
protein (CHOP), a transcriptional factor which promotes apoptosis under prolonged ER stress [32].
Data reported in Figure 2C show that, in HCT116 cells, EtOH significantly upregulates the levels of
Grp78 after 24 h (p < 0.05). In addition, EtOH upregulates CHOP level already after 3 h. After 24 h its
level remains higher (2.2-fold, p < 0.05) in 100 mM EtOH-treated cells than untreated ones, while it
lowers (0.8-fold) in cells exposed to 300 mM EtOH (Figure 2C). EtOH increases the levels of ER stress
markers also in HT29 and Caco-2 cells, although the effects were observed after a prolonged time of
treatment (24 h) (Figure S1).
We then evaluated the activation of ATF6 and PERK, two unfolding protein response (UPR)
sensors which promotes adaptive signal transduction under ER stress [32]. When unfolded proteins
increase, the full-length ATF6 is cleaved at Golgi into an active fragment (ATF6f), which migrates into
the nucleus upregulating the expression of chaperones, including GRP78 and CHOP [32]. Treatment of
HCT116 cells with EtOH decreases the ATF6 full-length protein at 3 h and concomitantly increases
that of ATF6f, suggesting the activation of the factor. These effects are not observed at 24 h of
EtOH treatment (Figure 2C). Moreover, EtOH treatment also promotes an early PERK increase that
significantly (p < 0.05) occurs already at 3 h of treatment (Figure 2C).
2.4. Ethanol Stimulates A Prosurvival Effect Sustained by An Autophagic Flux In Colon Cancer Cells
Under ER stress condition, autophagy can be activated to degrade unfolded/aggregated proteins
in order to maintain cell survival [33,34]. To assess whether this process occurs in our system model,
the presence of autophagic vacuoles was evaluated using fluorescence microscopy by staining the cells
with monodansylcadaverine (MDC). As Figure 3A shows, dot-likes structures appear in the cytoplasm
of EtOH-treated HCT116 cells. MDC-positive fluorescent cells are already observed after 24 h of
treatment with both 100 and 300 mM ethanol. The addition of the antioxidant N-acetylcysteine (NAC)
to EtOH-treated cells markedly reduces the presence of autophagic vacuoles (Figure 3A), suggesting
that autophagy is activated in response to oxidative stress as a prosurvival mechanism.
Then, we analyzed the levels of the autophagic markers by western blotting (Figure 3B).
Microtubule-associated protein light chain 3 (LC3) can be present in two different forms: a cytosolic
form (LC3-I) and an active lipidated form (LC3-II) [35], which is bound to the autophagosome
membrane [36]. As shown in Figure 3B, in HCT116 cells EtOH treatment favors the conversion
of LC3-I to LC3-II.
In addition to LC3, the level of beclin—a protein which plays an essential role in autophagosome
formation—was evaluated. Data reported in Figure 3B demonstrate that beclin protein level is
significantly higher after 3 h of treatment with 300 mMEtOH compared to untreated control (p < 0.05).
The level remains elevated after 24 h.
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DAPI filter. Results are representative of three independent experiments. (B) Western blotting analysis
of LC3, beclin, ATG7, and p62 in HCT116 cells treated for the indicated times with 100 or 300 mM
EtOH. Quantitative estimations of the protein levels were determined by densitometry measurements
of Western blotting from three independent experiments after normalization with β-actin. (*) p < 0.05
compared to the untreated sample.
Moreover, EtOH treatment increases the level of ATG7, an essential regulator of autophagosome
assembly [37]. As shown in the same Figure 3B, ATG7 level significantly (p < 0.05) increased after 24 h
treatment with 100 mM EtOH with respect to the untreated sample (Figure 3B).
Finally, we also examined the level of p62, a multifunctional protein considered as a marker of
autophagic flux. p62 is localized to the autophagosome via LC3 interaction and is constantly degraded
by the autophagy–lysosome system [38]. The analysis of p62 shows that EtOH increases the content of
this protein at 3 h of treatment, while its level lowers after 24 h (Figure 3B), thereby suggesting that
HCT116 cells treated with ethanol undergo to a complete autophagic process.
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2.5. Ethanol Activates Nrf2-Dependent Antioxidant Pathway
Despite the activation of oxidative and ER stress by EtOH, MTT cell viability and clonogenic
assay, reported in Figure 1, show that colon cancer cells survive even after prolonged treatment with
high doses of EtOH, thus suggesting the activation of an antioxidant response.
Nrf2 is one of the major transcription factors that promotes cellular defense against oxidative
stress. Nrf2 is maintained in an inactive cytosolic complex with Keap1 [39]. Our data show that Nrf2
level is enhanced in HCT116 cells treated with EtOH. In fact, in comparison with control cells the
level of Nrf2 protein increases with 300 mM EtOH approximately by 1.5-fold (p < 0.05) after 3 h of
treatment (Figure 4). Data reported in the same Figure 4, also demonstrate that the increase of Nrf2 is
accompanied by a significant decrease of Keap1 in cells treated for 3 h with 300 mM EtOH compared
to untreated control (p < 0.05).
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It is known that Nrf2 controls the transcription of many antioxidant and detoxifying genes, such as
superoxide dismutase (MnSOD), catalase, and heme oxygenase (HO-1) [21]. We demonstrated that the
levels of these proteins transcriptionally regulated by Nrf-2 markedly increase after 24 h of treatment
with 300 mMEtOH (Figure 4). In particular, the increase in the presence of 300 mM EtOH is estimated
1.4-fold for catalase, 4-fold for MnSOD (p < 0.001), and 5.5-fold for HO-1 (p < 0.001) after 24 h of
treatment (Figure 4). An increase in the levels of Nrf-2 and HO-1 is also observed in both HT29 and
Caco-2 cells after EtOH treatment (Figure S2).
2.6. Ethanol Promotes Nrf2 and HO-1 Translocation
Then we analyzed if the Nrf2 increase is accompanied by its nuclear translocation. Western
blotting analysis showed that Nrf2 is present in both nuclear and cytosolic fraction in untreated HCT116
cells and that EtOH treatment increases the nuclear level of Nrf2, while, concomitantly, decreases its
cytosolic fraction (Figure 5A). The analyses by confocal microscopy confirmed that in control cells Nrf2
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is preferentially distributed in the cytoplasm, while in treated cells the immunoreactivity is mainly
nuclear (Figure 5B).
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Figure 5. Ethanol induces the nuclear translocation of cytosolic Nrf2 and HO-1 in HCT116 cells.
(A) Cells were treated for 3 h and 24 h with 300 mM EtOH. Equal amounts of nuclear or cytosolic
proteins (30 µg) were analyzed by Western blotting and quantified by densitometry for Nrf2 and
HO-1 expression normalized against Lamin B and β-actin. Representative blots of three independent
experiments are shown. (*) p < 0.05 and (**) p < 0.01 compared to the untreated sample. (B) HCT116
cells (8 × 103) were grown on coverslips and treated for 24 h with 300 mM EtOH. EtOH-induced
nuclear translocation was observed under confocal microscope TCS SP8 employing Nrf2 or HO-1
specific antibodies followed by incubation with a fluorescein isothiocyanate (FITC) conjugated
IgG secondary antibody (green). The cells were also stained with Hoechst (blue fluorescence) to
visualize nuclear morphology. Original magnification: 400×. The results are representative of three
independent experiments.
It has been reported that HO-1 can undergo to intramembrane proteolysis and translocation
into the nucleus to sustain tumor survival and invasiveness without depending on its enzymatic
activity [40]. Interestingly, western blotting analyses showed that EtOH is able to increase nuclear
HO-1 levels (Figure 5A). This effect was already observed after 3h of treatment with 300 mM EtOH
(p < 0.01). Nuclear HO-1 translocation in EtOH-treated cells was also confirmed by confocal microscopy
experiments (Figure 5B, white arrows).
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2.7. Ethanol Increases MMPs and VEGF in Colon Cancer Cells
Given that metalloproteases (MMPs) are critical to cell invasion and metastasis [41], the expression
and activity of MMP2 and MMP9 in EtOH-treated HCT116 cells were examined by both Western
blotting analysis and gelatin zymography. Our results show that there is a significant increase in the
protein level of active MMP2 (7-fold, p < 0.001) in HCT116 cells treated with 300 mM EtOH already
after 24 h of treatment (Figure 6A). A minor increase (2.2-fold, p < 0.01) is observed for active MMP9
(Figure 6A). Moreover, gelatin zymography showed that 300 mM EtOH also increases the activity of
both metalloproteinases (Figure 6B).
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Finally, we also demonstrated that EtOH increases the level of vascular endothelial growth factor
(VEGF) in HCT116 cells. As shown in Figure 6A, in comparison with untreated cells, the level of
VEGF protein significantly increases after 24 h in EtOH-treated HCT116 cells approximately by 3.5-fold
(p < 0.01) with 100 mM and by 3.2 fold (p < 0.01) with 300 mM, respectively.
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2.8. Role of Nrf2/HO-1 Axis in Colon Cancer Survival and Aggressiveness
To further demonstrate the contribution of Nrf2 in protecting colon cancer cells by oxidative
damage induced by EtOH, Nrf2 was downregulated by transfecting HCT116 cells with a specific
siRNA pool directed against Nrf2. Western blotting analysis showed that the levels of Nrf2 protein in
siNrf2-transfected group are significantly decreased (p < 0.05) after 24 h compared with the siRNA
control group (Figure 7). Interestingly, the increases in HO-1 and MnSOD protein level caused by
300 mM EtOH treatment is suppressed by Nrf2 siRNA (Figure 7A), thus confirming that the expression
of such antioxidant proteins is under Nrf2 control. Moreover, cell viability assay showed that Nrf2
silencing reduces HCT116 cell viability (Figure 7B), thus suggesting a protective role of Nrf2 axis
against EtOH-mediated toxic effect.
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Furthermore, to evaluate whether also nuclear HO-1 translocation favors the survival of
EtOH-treated colon cancer cells, HCT116 cells were incubated in the presence of E64d, an inhibitor
of the protease responsible for the proteolytic cleavage of HO-1, an event necessary for its nuclear
translocation [42]. Combination of E64d with 300 mM EtOHis accompanied by a significant reduction
in nuclear localization of HO-1 (p <0.05) (Figure 8A). In addition, the data showed that inhibition of
nuclear translocation of HO-1 by E64d significantly reduces the EtOH-induced increase of MnSOD
(Figure 8B), thus supporting the conclusion that nuclear HO-1 could regulate MnSOD expression.
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It has been reported that both Nrf2 and HO-1 activation promote tumor progression by regulating
proinvasive and angiogenetic factors [22,43]. Thus, further analyses were performed to examine
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whether the Nrf2/HO-1 axis also plays a role in the acquisition of a tumor aggressive phenotype in
EtOH-treated colon cancer cells. As reported in Figures 7 and 8, in HCT116 cells the increase in MMP2
protein level induced by EtOH treatment at 300 mM is significantly (p < 0.05) suppressed by both
Nrf2 siRNA (Figure 7A) and E64d (Figure 8B). Moreover, the increase in VEGF level in EtOH-treated
cells is reduced by Nrf2 silencing (Figure 7A) and prevented by E64d (Figure 8B). These data indicate
that activation of Nrf2/HO-1 axis could enhance colon cancer progression by inducing MMP2 and
VEGF expression.
3. Discussion
Epidemiological studies highlighted that heavy alcohol drinking promotes colon cancer
progression [44], although the underlying molecular mechanisms are still not clear. Data reported
in this paper show that colon cancer cells survive even under treatment with high doses of ethanol
(100–300 mM), which have been shown to exert toxic effects in other tumor cell lines [45,46]. It is
interesting to note that concentrations ranging from 10 to 100 mM correspond to blood levels in
humans that could result from moderate-to-heavy alcohol drinking [47].
Supportive signs of evidence suggest that EtOH is able to increase ROS level in different cell
lines, including colon cancer cells, through both ADH and CYP2E1 activity [48]. Moreover, chronic
EtOH exposure causes inflammation in different organs, like pancreas and liver, as indicated by
the increase in proinflammatory cytokines and chemokines [49,50]. In line with these observations,
we demonstrated that EtOH stimulates oxidative stress and an inflammatory response in colon cancer
cells. This conclusion is supported by several pieces of evidence, such as rapid ROS production,
the increase in the levels of two enzymatic markers of inflammation iNOS and COX2, and the
upregulation of Hsp90 and Hsp60 induced by EtOH in colon cancer cells.
Our results also provided evidence that high doses of EtOH trigger ER stress as demonstrated by
upregulation of the ER stress markers Grp78, CHOP, and PERK, as well as the increase in the active
form of the transcription factor ATF6. These results are in line with the observation that ER stress
contributes to alcoholic damage of major organs such as liver, pancreas, and brain [51,52].
Accumulating evidence suggest that activation of autophagy, which degrades proteins in
organelles such as mitochondria and the ER, can play a protective role against the toxic effects
of ER stress [53]. On the other hand, ER stress can activate autophagy and there is a considerable
cross-talk between the ER and autophagy [54]. It has been reported that ER stress-activated PERK
promotes the phosphorylation of eIF2α to induce the activation of LC3, an autophagosome marker [55].
Moreover, Shimodaira et al. [33] demonstrated that in colon cancer cells activation of ER marker
CHOP promotes autophagy by activating inositol-requiring enzyme 1α (IRE1α). Our results provide
evidence that EtOH induced autophagy in colon cancer cells as demonstrated by the augmented
accumulation of acidic intracellular compartments. This effect is prevented by the addition of the
antioxidant N-acetylcysteine, thus suggesting that autophagy is activated as a survival mechanism in
response to oxidative stress. Our results are in line with the observation that EtOH activates autophagy
in neuronal cells to prevent the oxidative damage of ROS [56]. The activation of autophagy in our
system was also confirmed by the observation that EtOH promoted the cleavage of the cytosolic
form of LC3-I to LC3-II, as well increasing the level of beclin and ATG7, two factors involved in the
autophagosome formation [37]. Moreover, the observation that the level of p62 protein, a marker
of autophagic degradation, decreases after 24 h of EtOH treatment, which suggested to us that the
compound is able to trigger a complete autophagic flux.
In response to oxidative and ER stress production, we showed a significant activation of Nrf2,
a transcription factor which acts as a key regulator of antioxidant-responsive genes [57]. Under our
experimental conditions, EtOH promotes nuclear Nrf2 translocation, as suggested by the increase of
nuclear Nrf2 content already at 3 h following EtOH treatment. This event is a consequence of the
decrease of Keap1, a protein which in unstressed conditions sequesters Nrf2 in a cytoplasmic complex
leading to its ubiquitination and consequent proteasomal degradation [58]. Nuclear translocation of
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Nrf2 by EtOH could be promoted by oxidative events, in line with the observation that induction
of oxidative stress triggers Nrf2 nuclear import through the oxidation of redox-sensitive cysteines
within Keap1 [59]. Moreover, nuclear translocation could be also favored by ER stress activation.
In fact, it has been shown that phosphorylation of Nrf2 by PERK—a kinase activated following the
accumulation of unfolded proteins in ER—promotes dissolution of Nrf2/Keap1 complexes and Nrf2
nuclear import [60].
Activation of Nrf2 is responsible for transcription of a battery of genes encoding antioxidant
enzymes such as MnSOD, catalase, and HO-1 [61]. Our data indicated that the level of both MnSOD and
HO-1 is significantly upregulated after EtOH treatment in colon cancer cells, suggesting a protective
role of these enzymes against EtOH-induced oxidative stress. The observation that Nrf2 silencing
significantly reduces EtOH-induced HO-1 and MnSOD increase suggest to us that this effect is
mediated by the activation of Nrf2 transcriptional activity.
Interestingly, our data also provide evidence that EtOH promotes HO-1 nuclear translocation
already after 3 h of treatment. Nuclear expression of HO-1 has been detected in several tumors
and it has been correlated with tumor growth and invasion [43]. Our data showed that inhibition
of HO-1 nuclear translocation by the protease inhibitor E64d significantly reduces EtOH-induced
MnSOD increase, suggesting that HO-1 nuclear translocation could cooperate with Nrf2 to stimulate
antioxidant response and colon cancer cell survival. This suggestion is in accordance with some recent
evidence that demonstrates that nuclear HO-1 modulates the activation of Nrf2, leading to activation
of antioxidant genes [27].
Activation of the Nrf2/HO-1 axis represents a double-edged sword in cancer [61]. Increase in
antioxidant enzymes by Nrf2 prevents the development of tumors by counteracting the genotoxic
damage induced by ROS [62]. In line with this consideration, several dietary phytochemicals exert
a cancer preventive effect by activating the Nrf2/HO-1 axis [63,64]. Moreover, activation of Nrf2
reduces chronic inflammation which has been correlated with CRC induction [65]. On the other
hand, activation of the Nrf2/HO-1 antioxidant response in tumor cells can promote tumor survival by
creating an optimal environment for cell growth [61]. Overexpression of Nrf2 has been detected in
primary CRC and metastatic tissues relative to normal colon and contributes to chemoresistance in CRC
cell lines [66]. In addition, it has been reported that Nrf2 increases CRC risk by promoting angiogenesis
and uncontrolled proliferation [67]. Moreover, HO-1 overexpression has been associated with a more
aggressive behavior of tumors and poor prognosis in various cancers [68,69]. Western blotting and
zymography analyses demonstrated that EtOH increases both the levels and the activity of MMP-2 and
9—two enzymes involved in tumor progression—and upregulates VEGF, the main angiogenetic factor.
Interestingly, Nrf2 silencing prevented EtOH-induced MMP-2 increase and reduced that of VEGF.
Moreover, inhibition of HO-1 nuclear translocation by E64d counteracted the effect of EtOH on both
MMP-2 and VEGF, thus markedly suggesting a role of Nrf2/HO-1 axis in colon cancer progression.
Collectively, our findings demonstrate that high doses of EtOH enhance autophagy and activation
Nrf2/HO-1 axis in colon cancer cells. These events sustain the survival of cancer cells protecting
them from oxidative and ER stress induced by EtOH. Moreover, we show, for the first time, that the
activation of Nrf2/HO-1 axis could be also responsible for colon cancer progression through the
acquisition of a metastatic behavior, as demonstrated by the increase in the levels of MMP-2 and
VEGF. A schematic model of EtOH effects on colon cancer cells is shown in Figure 9. This study
provides a novel mechanistic link between ethanol-induced activation of Nrf2/HO-1 pathway and
increased survival and aggressiveness of colon cancer cells in in vitro models. However, to open to
this new scenario, further in vivo investigations are strongly required to sustain the role of Nrf2/HO-1
activation in CRC progression. Detection of Nrf2 and HO-1 overexpression in CRC biopsies of alcohol
drinkers could be, indeed, used as potential novel biomarkers to monitor CRC progression.
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4. Materials and Methods
4.1. Cell Cultures and Chemicals
The human colon cancer lines HCT116, HT29, and Caco-2 (Interlab Cell Line Collection, ICLC,
Genova, Italy) were grown in monolayer in flasks of 75 cm2 in RPMI 1640 medium, supplemented
with 10% (v/v) heat-inactivated fetal bovine serum (FBS), 2 mM L-glutamine, 100 U/mL penicillin,
and 50 µg/mL streptomycin in a humidified atmosphere of 5% CO2 in air at 37 ◦C. To study the
effects of ethanol (EtOH), cells were detached using trypsin-EDTA (0.5 mg/mL trypsin and 0.2 mg/mL
EDTA) and plated in accordance to the experimental conditions, as described in the paragraphs below.
Cells were allowed to adhere for 24 h and then treated with different concentrations of EtOH at
different times.
All the reagents used for cell cultures were purchased from Euroclone (Pero, Italy). EtOH,
E64d and all chemicals, except when stated otherwise, were supplied by Sigma-Aldrich (Milan, Italy).
4.2. Cell Viability
To evaluate the effect of EtOH on cell viability the MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl
tetrazolium bromide) colorimetric assay was used as previously reported [70]. In brief, HCT116,
HT29, and Caco-2 cells (7 × 103/200 µL/well) were plated in 96-wells and treated with various
concentrations of EtOH (30–300 mM) for different times. Fresh ethanol-containing medium was added
to cells daily. Then, 20 µL MTT (11 mg/mL) was added and cells were incubated at 37 ◦C for 4 h.
Finally, the medium was removed and 100 µL of lysis buffer (20% sodium dodecyl sulfate in 50%
N,N-dimethylformamide) was added. At the end, the absorbance of the formazan was measured
directly at 490 nm with 630 nm as a reference wavelength using an automatic ELISA plate reader
(OPSYS MR, Dynex Technologies, Chantilly, VA, USA). Cell viability was expressed as the percentage of
the OD value of EtOH-treated cells compared with untreated samples used as control. Each experiment
was performed in triplicate. The viability of cells was also assessed through the use of propidium
iodide (PI) dye exclusion assay. The intact membrane of live cells excludes a variety of dyes that easily
penetrate the damaged, permeable membranes of dead cells. After incubation with ethanol, 2 µg/mL
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PI was added and the incubation was protracted for 15 min before the visualization of cell morphology
by a Leica DC 300F microscope (Leica microsystems, Wetzlar, Germany) equipped with a rhodamine
filter (excitation wavelength of 596 nm and emission wavelength of 620 nm). Also, cell morphology
was visualized using a Leica DC 300F microscope inverted.
4.3. Clonogenic Assay
For the colony formation assay, a single cell suspension (200 cells/well) was plated into each well
of a 6-well plate and incubated at 37 ◦C for 2 weeks. The colonies were fixed and stained with a dye
solution containing crystal violet as reported by Raffa et al. [71]. All assays were replicated three times.
4.4. Western Blotting Analysis
Cell lysates were prepared as reported [72] and protein concentration was determined by Bradford
Protein Assay (Bio-Rad Laboratories S.r.l., Segrate, Milan, Italy). Protein extracts (30 µg/sample) were
subjected to SDS-polyacrylamide gel electrophoresis. Then, proteins were blotted on nitrocellulose
membranes. Primary antibodies used for the identification of catalase, Lamin B, MnSOD, Nrf2, iNOS,
COX2, Grp78, Chop, MMP2, MMP9, and PERK (1:200) were purchased from Santa Cruz Biotechnology
(St. Cruz, CA, USA); β-actin (1:1000) from Sigma Aldrich; Hsp60, Hsp90, and HO-1 (1:1000) from
Enzo Life Sciences, (Milan, Italy), ATG7 (1:1000) from Cell Signaling Tecnology (Beverly, MA, USA);
and ATF6 (1:300) from Novus Biologicals (Milano, Italy). Membranes were then incubated with
HRP-conjugated secondary antibody (1:5000) (Pierce, Thermo Fisher Scientific, Loughborough, UK)
and the signals were detected using enhanced chemiluminescence (ECL) reagents (Cyanagen, Bologna,
Italy). The signal obtained was visualized and photographed with ChemiDoc XRS (Bio-Rad, Hercules,
CA, USA). After analysis, membranes were stripped (200 mM glycine, 0,1% SDS, 1% Tween 20,
pH 2.2) and reincubated. The intensity of the bands was performed using Quantity One software
(Bio-Rad). After checking that β-actin content was not modified by ethanol treatment vs untreated
sample, in accordance with Lamichhane et al. [73], β-actin was used as a loading control and for band
normalization. All the blots shown are representative of at least three separate experiments.
4.5. Extraction of Cytosolic and Nuclear Fraction
HCT116 cells were seeded in 100-mm tissue culture dishes (1 × 106 cells/5 mL culture medium)
and, after treatment with EtOH, were lysed as reported [74]. In particular, cells were washed in PBS
and scraped with lysis buffer (250 mM Sucrose, 20 mM HEPES, 10 mM KCl, 1.5 mM MgCl2, 1 mM
EDTA, 1 mM EGTA, 1 mM DTT, and protease inhibitors, pH 7.4). Next, cells were passed 10 times
through a needle of 25 g on ice for 20 min. The homogenates were centrifuged at 1000× g for 10 min at
4 ◦C. The pellets were resuspended in lysis buffer and passed 10 times through a needle of 25 g and
centrifuged at 1000× g for 10 min at 4 ◦C. The pellets of the second centrifugation (nuclear fraction)
were lysed with RIPA buffer (1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS, inhibitors of proteases:
25 µg/mL aprotinin, 1 mM PMSF, 25 µg/mL leupeptin, and 0.2 mM sodium pyrophosphate) and
sonicated. The supernatants obtained from the first centrifugation were centrifuged at 10,000× g for
30 min at 4 ◦C. The supernatants obtained were considered as cytosolic fraction. Nuclear and cytosolic
fractions were used to evaluate Nrf2 and HO-1. β-actin and LaminB were used as cytoplasmic and
nuclear markers, respectively.
4.6. Monodansylcadaverine Test
To evaluate the formation of autophagic vacuoles monodansylcadaverine (MDC) test was
employed as reported [75]. HCT116 cells (7 × 103/200 µL culture medium) were plated in 96-wells
plates and treated with EtOH. After treatment, cells were incubated with 50 µM MDC for 10 min at
37 ◦C in the darkness. Then, cells were washed with PBS and analysed by fluorescence microscopy
using a Leica DMR (Leica Microsystems, Milan, Italy) microscope equipped with a DAPI filter system
(excitation wavelength of 372 nm and emission wavelength of 456 nm). Images were acquired by
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computer imaging system (Leica DC300F camera, Milan, Italy). Three different visual fields were
examined for each condition.
4.7. Nrf2 siRNA Transfection
RNA interference of Nrf2 was performed using FlexiTube siRNA (SI03246950, SI03246614 Qiagen,
Hilden, Germany) targeting Nrf2. A nonsilencing siRNA (SI03650318, Qiagen) was used as a negative
control. As previously reported [76] for transfection, HCT116 cells were seeded (2 × 105 cells/well)
in 6-well plates and cultured in antibiotic-free RPMI 1640 medium supplemented with 10% FBS for
24 h to reach approximately 60–80% confluence before transfection. Specific siRNAs (50 nM final
concentration) and negative siRNA control (50 nM) were transfected for 5 h into the cells in the
presence of 5 µL Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA) in a final volume of 1 mL
serum/antibiotic-free RPMI 1640 medium. The reaction was stopped by replacing the culture medium
with complete RPMI 1640 medium. After 24 h of transfection, cells were treated with EtOH for other
24 h or 48 h. Then, cells were employed for immunoblotting analysis or MTT.
4.8. Measurement of Intracellular ROS Content
Intracellular ROS production was detected using the cell-permeant 2′,7′-dichlorodihydrofluorescein
diacetate (H2DCFDCA Molecular Probes; Eugene, OR, USA) as described [77]. HCT116 cells
(7 × 103/200 µL) were seeded in 96-well plates and incubated with 300 mM EtOH for different times.
After treatment, cells were washed with PBS and incubated with a 10 µM H2DCFDA for 15 min at
37 ◦C in the dark. Finally, cells were resuspended in PBS and analyzed by fluorescence microscopy
using a Leica DMR (Leica Microsystems S.r.l., Wetzlar, Germany) inverted microscope equipped with
a FITC filter system (excitation wavelength of 485 nm and emission wavelength of 530 nm). Images
were acquired by computer imaging system (Leica DC300F camera). Three different visual fields were
examined for each condition.
4.9. Gelatin Zymography
HCT116 cells were seeded in 100-mm tissue culture dishes (5 × 105 cells/ 5 mL culture medium).
After 48 h of EtOH treatment, cells were washed in PBS and scraped with lysis buffer. The lysates were
centrifuged at 800× g for 10 min. The samples (50 µg of proteins prepared in sample buffer: 50 mM
Tris-HCl, 2% SDS, 0.1% Bromophenol Blue, 40% Glycerol, pH 6.8) were loaded on polyacrylamide
gels (10%) with 10× gelatin and subjected to electrophoresis. After, the gel was washed for 1 h with
enzyme renaturing buffer (200 mM NaCl, 5 mM CaCl2, 5 µM ZnCl2, 2,5% (v/v) Triton X-100 and
50 mM Tris-HCl, pH 7.5) and incubated overnight at 37 ◦C with developing buffer (50 mM Tris base,
200 mM NaCl, 5 mM CaCl2, pH 7.5). Then, the gel was incubated for 30 min at room temperature
with staining solution (0.125% Coomassie brilliant blue R-250, 50% methanol, 20% acetic acid) and
washed with destaining solution (30% methanol, 0,01% formic acid) until clear bands of MMP activity
are visible in the blue background.
4.10. Immunofluorescence
HCT116 cells (8 × 103) were plated on coverslips and treated with 300 mM EtOH for different
times. Immunofluorescence was performed as previously described [78,79]. Briefly, after washing
twice in PBS, cells were fixed in methanol for 30 min at room temperature. After fixation, cells were
washed three times in PBS for 5 min and treated with a blocking solution (3% BSA in PBS) for 30 min.
Subsequently, the cells were washed twice in PBS and incubated with the primary antibody directed
against HO-1 (anti-rabbit, Enzo Life Sciences) or against Nrf2 (anti-rabbit, Santa Cruz Biotecnology,
St Cruz, CA, USA) at a dilution 1:100, overnight at 4 ◦C. Then, cells were washed three times in PBS
for 5 min and incubated for 1h with a conjugated secondary antibody: anti-rabbit IgG–FITC produced
in goat (Sigma-Aldrich) at dilution 1:200. Nuclei were stained with Hoechst Stain Solution (1:1000,
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Hoechst 33258, Sigma-Aldrich). The images were captured using a Leica Confocal Microscope TCS
SP8 (Leica Microsystems). Ten random visual fields were examined for each condition.
4.11. Statistical Analysis
Data were represented as mean ± S.E. and analysis was performed using the Student’s t-test
and one-way analysis of variance. Comparisons between the control (untreated) vs. all treated
samples were made. If a significant difference was detected by ANOVA analyses, this was re-evaluated
by post-hoc Bonferroni’s test. GraphPadPrismTM 4.0 software (Graph PadPrismTM Software Inc.,
San Diego, CA, USA) was used for statistical calculations. The statistical significance threshold was
fixed at p < 0.05.
5. Conclusions
In summary, cell culture experiments performed in three different colon cancer cell lines
demonstrate that nuclear translocation and consequent activation of both Nrf2 and HO-1 in response to
high doses of ethanol exert a protective effect against the toxic effects of alcohol-induced oxidative and
ER stress. Moreover, Nrf2/HO-1 activation also favors the acquisition of a more aggressive phenotype
through the upregulation of proinvasive and angiogenetic factors like MMPs and VEGF. This might
represent a causative link between alcohol consumption and an increased risk of CRC progression.
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